Pannu Geraldine 4

4 · Processa Pharmaceuticals, Inc. · Filed Jan 4, 2023

Insider Transaction Report

Form 4
Period: 2022-12-31
Transactions
  • Award

    Restricted Stock

    2023-01-01+30,00030,000 total
    Exercise: $0.00Common Stock (30,000 underlying)
  • Exercise/Conversion

    Common Stock

    2022-12-31+18,20829,477 total
Footnotes (2)
  • [F1]Vesting of time-based restricted shares.
  • [F2]The restricted stock vests on the earliest of one year from date of grant or the next annual meeting of stockholders.

Documents

1 file
  • 4
    doc1.xmlPrimary

    FORM 4